RCUS Arcus Biosciences Inc

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company which focuses on developing and commercializing cancer immunotherapies.

$27.02  +3.62 (15.47%)
As of 06/24/2021 16:00:02 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/15/2018
Outstanding shares:  70,995,860
Average volume:  636,235
Market cap:   $1,615,155,815
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    03969F109
ISIN:        US03969F1093
Sedol:      BDZT9Y9
Valuation   (See tab for details)
PE ratio:   -9.91
PB ratio:   2.50
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy